Wealth Enhancement Advisory Services »

Lexicon Pharmaceuticals shares owned by Wealth Enhancement Advisory Services

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by Wealth Enhancement Advisory Services from 13F filings

Historical chart of Wealth Enhancement Advisory Services investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by Wealth Enhancement Advisory Services consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by Wealth Enhancement Advisory Services

Quarter filed Position value Share count Share price at filing
2025-09-30 $29k 19k 1.52
2025-06-30 $67k 75k 0.90
2025-03-31 $32k 69k 0.46

More positions owned by Wealth Enhancement Advisory Services

Ishares Tr Core S&p500 Etf (IVV)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)
Alps Etf Tr Smith Core Plus (SMTH)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Ishares Tr Msci Intl Moment (IMTM)
Amazon (AMZN)
J P Morgan Exchange Traded F Us Momentum (JMOM)
Schwab Strategic Tr Fundamental Intl (FNDF)
Victory Portfolios Ii Usaa Msci Usa Sm (USVM)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Ishares Tr Msci Usa Min Vol (USMV)
Ishares Tr Us Treas Bd Etf (GOVT)
Invesco Exchange Traded Fd T S&p500 Quality (SPHQ)
Vanguard Index Fds S&p 500 Etf Shs (VOO)

View all positions for Wealth Enhancement Advisory Services

Top funds holding Lexicon Pharmaceuticals

Artal Group
Siren
FMR
Vanguard Group
Millennium Management
BlackRock
Citadel Advisors
Sessa Capital IM
Atlantic Trust
Geode Capital Management
Caption Management
Susquehanna International
GSA Capital Partners
Charles Schwab Investment Management
State Street Corporation

View all funds holding Lexicon Pharmaceuticals